nodes	percent_of_prediction	percent_of_DWPC	metapath
Pravastatin—ABCB1—peripheral nervous system neoplasm	0.223	1	CbGaD
Pravastatin—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0519	0.0936	CbGbCtD
Pravastatin—ABCB11—Vincristine—peripheral nervous system neoplasm	0.0466	0.084	CbGbCtD
Pravastatin—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.036	0.0648	CbGbCtD
Pravastatin—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.0291	0.0525	CbGbCtD
Pravastatin—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0267	0.0482	CbGbCtD
Pravastatin—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0257	0.0463	CbGbCtD
Pravastatin—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0245	0.0442	CbGbCtD
Pravastatin—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0229	0.0412	CbGbCtD
Pravastatin—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0225	0.0405	CbGbCtD
Pravastatin—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0222	0.0399	CbGbCtD
Pravastatin—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0207	0.0372	CbGbCtD
Pravastatin—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0203	0.0366	CbGbCtD
Pravastatin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0187	0.0337	CbGbCtD
Pravastatin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0187	0.0337	CbGbCtD
Pravastatin—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0179	0.0323	CbGbCtD
Pravastatin—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0153	0.0276	CbGbCtD
Pravastatin—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0138	0.025	CbGbCtD
Pravastatin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.013	0.0234	CbGbCtD
Pravastatin—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0123	0.0221	CbGbCtD
Pravastatin—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0113	0.0203	CbGbCtD
Pravastatin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0112	0.0202	CbGbCtD
Pravastatin—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0108	0.0195	CbGbCtD
Pravastatin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0104	0.0188	CbGbCtD
Pravastatin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00799	0.0144	CbGbCtD
Pravastatin—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00768	0.0138	CbGbCtD
Pravastatin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00745	0.0134	CbGbCtD
Pravastatin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00732	0.0132	CbGbCtD
Pravastatin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00499	0.009	CbGbCtD
Pravastatin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00479	0.00863	CbGbCtD
Pravastatin—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00471	0.00848	CbGbCtD
Pravastatin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00439	0.00791	CbGbCtD
Pravastatin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00299	0.00539	CbGbCtD
Pravastatin—Simvastatin—ABCB1—peripheral nervous system neoplasm	0.000953	0.505	CrCbGaD
Pravastatin—Lovastatin—ABCB1—peripheral nervous system neoplasm	0.000933	0.495	CrCbGaD
Pravastatin—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000544	CcSEcCtD
Pravastatin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000115	0.000544	CcSEcCtD
Pravastatin—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000543	CcSEcCtD
Pravastatin—Rash—Melphalan—peripheral nervous system neoplasm	0.000114	0.000543	CcSEcCtD
Pravastatin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000114	0.000542	CcSEcCtD
Pravastatin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.00054	CcSEcCtD
Pravastatin—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000539	CcSEcCtD
Pravastatin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000113	0.000538	CcSEcCtD
Pravastatin—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000113	0.000537	CcSEcCtD
Pravastatin—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000536	CcSEcCtD
Pravastatin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000112	0.000531	CcSEcCtD
Pravastatin—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000111	0.00053	CcSEcCtD
Pravastatin—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000526	CcSEcCtD
Pravastatin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000111	0.000525	CcSEcCtD
Pravastatin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000525	CcSEcCtD
Pravastatin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000522	CcSEcCtD
Pravastatin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000522	CcSEcCtD
Pravastatin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00011	0.000522	CcSEcCtD
Pravastatin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00011	0.000521	CcSEcCtD
Pravastatin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000109	0.00052	CcSEcCtD
Pravastatin—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000519	CcSEcCtD
Pravastatin—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000519	CcSEcCtD
Pravastatin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000109	0.000518	CcSEcCtD
Pravastatin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000109	0.000518	CcSEcCtD
Pravastatin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000109	0.000516	CcSEcCtD
Pravastatin—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000516	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000513	CcSEcCtD
Pravastatin—Infection—Etoposide—peripheral nervous system neoplasm	0.000108	0.000512	CcSEcCtD
Pravastatin—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000512	CcSEcCtD
Pravastatin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000108	0.000511	CcSEcCtD
Pravastatin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000108	0.000511	CcSEcCtD
Pravastatin—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000508	CcSEcCtD
Pravastatin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000505	CcSEcCtD
Pravastatin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000106	0.000505	CcSEcCtD
Pravastatin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000503	CcSEcCtD
Pravastatin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000106	0.000503	CcSEcCtD
Pravastatin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000106	0.000503	CcSEcCtD
Pravastatin—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000502	CcSEcCtD
Pravastatin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000502	CcSEcCtD
Pravastatin—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000499	CcSEcCtD
Pravastatin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000105	0.000499	CcSEcCtD
Pravastatin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000498	CcSEcCtD
Pravastatin—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000495	CcSEcCtD
Pravastatin—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000103	0.000492	CcSEcCtD
Pravastatin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.00049	CcSEcCtD
Pravastatin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000103	0.000489	CcSEcCtD
Pravastatin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000103	0.000488	CcSEcCtD
Pravastatin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000102	0.000487	CcSEcCtD
Pravastatin—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000487	CcSEcCtD
Pravastatin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000101	0.000481	CcSEcCtD
Pravastatin—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00048	CcSEcCtD
Pravastatin—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00048	CcSEcCtD
Pravastatin—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000475	CcSEcCtD
Pravastatin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	9.98e-05	0.000474	CcSEcCtD
Pravastatin—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	9.97e-05	0.000473	CcSEcCtD
Pravastatin—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	9.95e-05	0.000472	CcSEcCtD
Pravastatin—Influenza—Doxorubicin—peripheral nervous system neoplasm	9.9e-05	0.00047	CcSEcCtD
Pravastatin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	9.87e-05	0.000469	CcSEcCtD
Pravastatin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	9.84e-05	0.000467	CcSEcCtD
Pravastatin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000466	CcSEcCtD
Pravastatin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	9.77e-05	0.000464	CcSEcCtD
Pravastatin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	9.77e-05	0.000464	CcSEcCtD
Pravastatin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	9.75e-05	0.000463	CcSEcCtD
Pravastatin—Weight increased—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000463	CcSEcCtD
Pravastatin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	9.71e-05	0.000461	CcSEcCtD
Pravastatin—Weight decreased—Epirubicin—peripheral nervous system neoplasm	9.68e-05	0.00046	CcSEcCtD
Pravastatin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	9.68e-05	0.00046	CcSEcCtD
Pravastatin—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	9.65e-05	0.000458	CcSEcCtD
Pravastatin—Asthenia—Vincristine—peripheral nervous system neoplasm	9.62e-05	0.000457	CcSEcCtD
Pravastatin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.54e-05	0.000453	CcSEcCtD
Pravastatin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	9.52e-05	0.000452	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	9.46e-05	0.000449	CcSEcCtD
Pravastatin—Rash—Dactinomycin—peripheral nervous system neoplasm	9.46e-05	0.000449	CcSEcCtD
Pravastatin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	9.44e-05	0.000448	CcSEcCtD
Pravastatin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	9.37e-05	0.000445	CcSEcCtD
Pravastatin—Fatigue—Etoposide—peripheral nervous system neoplasm	9.36e-05	0.000445	CcSEcCtD
Pravastatin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.000444	CcSEcCtD
Pravastatin—Jaundice—Epirubicin—peripheral nervous system neoplasm	9.3e-05	0.000442	CcSEcCtD
Pravastatin—Constipation—Etoposide—peripheral nervous system neoplasm	9.28e-05	0.000441	CcSEcCtD
Pravastatin—Pain—Etoposide—peripheral nervous system neoplasm	9.28e-05	0.000441	CcSEcCtD
Pravastatin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	9.27e-05	0.000441	CcSEcCtD
Pravastatin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	9.26e-05	0.00044	CcSEcCtD
Pravastatin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	9.2e-05	0.000437	CcSEcCtD
Pravastatin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	9.2e-05	0.000437	CcSEcCtD
Pravastatin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	9.17e-05	0.000436	CcSEcCtD
Pravastatin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	9.04e-05	0.000429	CcSEcCtD
Pravastatin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	0.000428	CcSEcCtD
Pravastatin—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	8.96e-05	0.000426	CcSEcCtD
Pravastatin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	8.95e-05	0.000425	CcSEcCtD
Pravastatin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	8.95e-05	0.000425	CcSEcCtD
Pravastatin—Nausea—Dactinomycin—peripheral nervous system neoplasm	8.91e-05	0.000423	CcSEcCtD
Pravastatin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	8.88e-05	0.000422	CcSEcCtD
Pravastatin—Dizziness—Vincristine—peripheral nervous system neoplasm	8.86e-05	0.000421	CcSEcCtD
Pravastatin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	8.84e-05	0.00042	CcSEcCtD
Pravastatin—Rash—Alitretinoin—peripheral nervous system neoplasm	8.77e-05	0.000417	CcSEcCtD
Pravastatin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	8.76e-05	0.000416	CcSEcCtD
Pravastatin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	8.75e-05	0.000416	CcSEcCtD
Pravastatin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	8.73e-05	0.000415	CcSEcCtD
Pravastatin—Headache—Alitretinoin—peripheral nervous system neoplasm	8.71e-05	0.000414	CcSEcCtD
Pravastatin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000411	CcSEcCtD
Pravastatin—Urticaria—Etoposide—peripheral nervous system neoplasm	8.62e-05	0.00041	CcSEcCtD
Pravastatin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000409	CcSEcCtD
Pravastatin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	8.59e-05	0.000408	CcSEcCtD
Pravastatin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	8.58e-05	0.000408	CcSEcCtD
Pravastatin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.58e-05	0.000408	CcSEcCtD
Pravastatin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	8.58e-05	0.000408	CcSEcCtD
Pravastatin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	8.57e-05	0.000407	CcSEcCtD
Pravastatin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	8.52e-05	0.000405	CcSEcCtD
Pravastatin—Vomiting—Vincristine—peripheral nervous system neoplasm	8.52e-05	0.000405	CcSEcCtD
Pravastatin—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.5e-05	0.000404	CcSEcCtD
Pravastatin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	8.5e-05	0.000404	CcSEcCtD
Pravastatin—Rash—Vincristine—peripheral nervous system neoplasm	8.45e-05	0.000401	CcSEcCtD
Pravastatin—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.44e-05	0.000401	CcSEcCtD
Pravastatin—Headache—Vincristine—peripheral nervous system neoplasm	8.4e-05	0.000399	CcSEcCtD
Pravastatin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	8.28e-05	0.000393	CcSEcCtD
Pravastatin—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.26e-05	0.000392	CcSEcCtD
Pravastatin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	8.25e-05	0.000392	CcSEcCtD
Pravastatin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.11e-05	0.000385	CcSEcCtD
Pravastatin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	8.1e-05	0.000385	CcSEcCtD
Pravastatin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8e-05	0.00038	CcSEcCtD
Pravastatin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	7.99e-05	0.000379	CcSEcCtD
Pravastatin—Nausea—Vincristine—peripheral nervous system neoplasm	7.96e-05	0.000378	CcSEcCtD
Pravastatin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	7.95e-05	0.000378	CcSEcCtD
Pravastatin—Flushing—Epirubicin—peripheral nervous system neoplasm	7.95e-05	0.000378	CcSEcCtD
Pravastatin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	7.95e-05	0.000377	CcSEcCtD
Pravastatin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	7.93e-05	0.000376	CcSEcCtD
Pravastatin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	7.89e-05	0.000375	CcSEcCtD
Pravastatin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000374	CcSEcCtD
Pravastatin—Asthenia—Etoposide—peripheral nervous system neoplasm	7.79e-05	0.00037	CcSEcCtD
Pravastatin—Chills—Epirubicin—peripheral nervous system neoplasm	7.69e-05	0.000365	CcSEcCtD
Pravastatin—Pruritus—Etoposide—peripheral nervous system neoplasm	7.68e-05	0.000365	CcSEcCtD
Pravastatin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	7.65e-05	0.000363	CcSEcCtD
Pravastatin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	7.64e-05	0.000363	CcSEcCtD
Pravastatin—Alopecia—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.00036	CcSEcCtD
Pravastatin—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.53e-05	0.000358	CcSEcCtD
Pravastatin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	7.49e-05	0.000356	CcSEcCtD
Pravastatin—Rash—Cisplatin—peripheral nervous system neoplasm	7.47e-05	0.000355	CcSEcCtD
Pravastatin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.46e-05	0.000355	CcSEcCtD
Pravastatin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.43e-05	0.000353	CcSEcCtD
Pravastatin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	7.39e-05	0.000351	CcSEcCtD
Pravastatin—Flushing—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000349	CcSEcCtD
Pravastatin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	7.36e-05	0.000349	CcSEcCtD
Pravastatin—Flatulence—Epirubicin—peripheral nervous system neoplasm	7.35e-05	0.000349	CcSEcCtD
Pravastatin—Tension—Epirubicin—peripheral nervous system neoplasm	7.32e-05	0.000348	CcSEcCtD
Pravastatin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	7.3e-05	0.000347	CcSEcCtD
Pravastatin—Nervousness—Epirubicin—peripheral nervous system neoplasm	7.24e-05	0.000344	CcSEcCtD
Pravastatin—Dizziness—Etoposide—peripheral nervous system neoplasm	7.18e-05	0.000341	CcSEcCtD
Pravastatin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	7.17e-05	0.000341	CcSEcCtD
Pravastatin—Chills—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000338	CcSEcCtD
Pravastatin—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	7.08e-05	0.000336	CcSEcCtD
Pravastatin—Nausea—Cisplatin—peripheral nervous system neoplasm	7.04e-05	0.000334	CcSEcCtD
Pravastatin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000334	CcSEcCtD
Pravastatin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	7e-05	0.000333	CcSEcCtD
Pravastatin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.92e-05	0.000329	CcSEcCtD
Pravastatin—Vomiting—Etoposide—peripheral nervous system neoplasm	6.9e-05	0.000328	CcSEcCtD
Pravastatin—Anaemia—Epirubicin—peripheral nervous system neoplasm	6.89e-05	0.000327	CcSEcCtD
Pravastatin—Rash—Etoposide—peripheral nervous system neoplasm	6.84e-05	0.000325	CcSEcCtD
Pravastatin—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.84e-05	0.000325	CcSEcCtD
Pravastatin—Headache—Etoposide—peripheral nervous system neoplasm	6.8e-05	0.000323	CcSEcCtD
Pravastatin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	6.8e-05	0.000323	CcSEcCtD
Pravastatin—Tension—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	0.000322	CcSEcCtD
Pravastatin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	6.76e-05	0.000321	CcSEcCtD
Pravastatin—Malaise—Epirubicin—peripheral nervous system neoplasm	6.72e-05	0.000319	CcSEcCtD
Pravastatin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	6.7e-05	0.000318	CcSEcCtD
Pravastatin—Vertigo—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000318	CcSEcCtD
Pravastatin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	6.67e-05	0.000317	CcSEcCtD
Pravastatin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	6.63e-05	0.000315	CcSEcCtD
Pravastatin—Cough—Epirubicin—peripheral nervous system neoplasm	6.51e-05	0.000309	CcSEcCtD
Pravastatin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000309	CcSEcCtD
Pravastatin—Nausea—Etoposide—peripheral nervous system neoplasm	6.45e-05	0.000306	CcSEcCtD
Pravastatin—Hypertension—Epirubicin—peripheral nervous system neoplasm	6.44e-05	0.000306	CcSEcCtD
Pravastatin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.4e-05	0.000304	CcSEcCtD
Pravastatin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	6.38e-05	0.000303	CcSEcCtD
Pravastatin—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000302	CcSEcCtD
Pravastatin—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000302	CcSEcCtD
Pravastatin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000302	CcSEcCtD
Pravastatin—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.0003	CcSEcCtD
Pravastatin—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.27e-05	0.000298	CcSEcCtD
Pravastatin—Malaise—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	0.000296	CcSEcCtD
Pravastatin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.000294	CcSEcCtD
Pravastatin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	6.18e-05	0.000293	CcSEcCtD
Pravastatin—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000291	CcSEcCtD
Pravastatin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000289	CcSEcCtD
Pravastatin—Oedema—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000289	CcSEcCtD
Pravastatin—Infection—Epirubicin—peripheral nervous system neoplasm	6.05e-05	0.000287	CcSEcCtD
Pravastatin—Cough—Doxorubicin—peripheral nervous system neoplasm	6.02e-05	0.000286	CcSEcCtD
Pravastatin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000283	CcSEcCtD
Pravastatin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	5.96e-05	0.000283	CcSEcCtD
Pravastatin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.88e-05	0.000279	CcSEcCtD
Pravastatin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000279	CcSEcCtD
Pravastatin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000279	CcSEcCtD
Pravastatin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000279	CcSEcCtD
Pravastatin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.000278	CcSEcCtD
Pravastatin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.8e-05	0.000276	CcSEcCtD
Pravastatin—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.8e-05	0.000276	CcSEcCtD
Pravastatin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.00027	CcSEcCtD
Pravastatin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000267	CcSEcCtD
Pravastatin—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000267	CcSEcCtD
Pravastatin—Infection—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.000266	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000263	CcSEcCtD
Pravastatin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.51e-05	0.000262	CcSEcCtD
Pravastatin—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.5e-05	0.000261	CcSEcCtD
Pravastatin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.00026	CcSEcCtD
Pravastatin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.44e-05	0.000259	CcSEcCtD
Pravastatin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.43e-05	0.000258	CcSEcCtD
Pravastatin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000255	CcSEcCtD
Pravastatin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.36e-05	0.000254	CcSEcCtD
Pravastatin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.29e-05	0.000251	CcSEcCtD
Pravastatin—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.000249	CcSEcCtD
Pravastatin—Pain—Epirubicin—peripheral nervous system neoplasm	5.2e-05	0.000247	CcSEcCtD
Pravastatin—Constipation—Epirubicin—peripheral nervous system neoplasm	5.2e-05	0.000247	CcSEcCtD
Pravastatin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.13e-05	0.000244	CcSEcCtD
Pravastatin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.09e-05	0.000242	CcSEcCtD
Pravastatin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.00024	CcSEcCtD
Pravastatin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	0.000238	CcSEcCtD
Pravastatin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000238	CcSEcCtD
Pravastatin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000236	CcSEcCtD
Pravastatin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.96e-05	0.000235	CcSEcCtD
Pravastatin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.000233	CcSEcCtD
Pravastatin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000231	CcSEcCtD
Pravastatin—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.00023	CcSEcCtD
Pravastatin—Pain—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000229	CcSEcCtD
Pravastatin—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000229	CcSEcCtD
Pravastatin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000229	CcSEcCtD
Pravastatin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000229	CcSEcCtD
Pravastatin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.00022	CcSEcCtD
Pravastatin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.6e-05	0.000219	CcSEcCtD
Pravastatin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000213	CcSEcCtD
Pravastatin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000212	CcSEcCtD
Pravastatin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000211	CcSEcCtD
Pravastatin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000211	CcSEcCtD
Pravastatin—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000207	CcSEcCtD
Pravastatin—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.31e-05	0.000205	CcSEcCtD
Pravastatin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.16e-05	0.000198	CcSEcCtD
Pravastatin—SLC22A7—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	4.15e-05	0.00437	CbGpPWpGaD
Pravastatin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.000197	CcSEcCtD
Pravastatin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.000192	CcSEcCtD
Pravastatin—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.02e-05	0.000191	CcSEcCtD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.01e-05	0.00422	CbGpPWpGaD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.99e-05	0.0042	CbGpPWpGaD
Pravastatin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.000189	CcSEcCtD
Pravastatin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	3.97e-05	0.00418	CbGpPWpGaD
Pravastatin—SLCO1B3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.94e-05	0.00415	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.93e-05	0.00414	CbGpPWpGaD
Pravastatin—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000184	CcSEcCtD
Pravastatin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.85e-05	0.000183	CcSEcCtD
Pravastatin—Rash—Epirubicin—peripheral nervous system neoplasm	3.84e-05	0.000182	CcSEcCtD
Pravastatin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.83e-05	0.000182	CcSEcCtD
Pravastatin—HMGCR—AMPK Signaling—TP53—peripheral nervous system neoplasm	3.81e-05	0.00402	CbGpPWpGaD
Pravastatin—Headache—Epirubicin—peripheral nervous system neoplasm	3.81e-05	0.000181	CcSEcCtD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.79e-05	0.00399	CbGpPWpGaD
Pravastatin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.72e-05	0.000177	CcSEcCtD
Pravastatin—ABCB11—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.7e-05	0.0039	CbGpPWpGaD
Pravastatin—Nausea—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000172	CcSEcCtD
Pravastatin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.00017	CcSEcCtD
Pravastatin—Rash—Doxorubicin—peripheral nervous system neoplasm	3.55e-05	0.000169	CcSEcCtD
Pravastatin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.55e-05	0.000168	CcSEcCtD
Pravastatin—Headache—Doxorubicin—peripheral nervous system neoplasm	3.53e-05	0.000168	CcSEcCtD
Pravastatin—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.49e-05	0.00367	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.46e-05	0.00364	CbGpPWpGaD
Pravastatin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	3.45e-05	0.00363	CbGpPWpGaD
Pravastatin—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	3.43e-05	0.00361	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.35e-05	0.00353	CbGpPWpGaD
Pravastatin—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.000159	CcSEcCtD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	3.33e-05	0.00351	CbGpPWpGaD
Pravastatin—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	3.29e-05	0.00346	CbGpPWpGaD
Pravastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	3.28e-05	0.00346	CbGpPWpGaD
Pravastatin—SLC16A1—Cell surface interactions at the vascular wall—NRAS—peripheral nervous system neoplasm	3.26e-05	0.00344	CbGpPWpGaD
Pravastatin—HMGCR—SREBP signalling—AKT1—peripheral nervous system neoplasm	3.22e-05	0.00339	CbGpPWpGaD
Pravastatin—HMGCR—AMPK Signaling—AKT1—peripheral nervous system neoplasm	3.22e-05	0.00339	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	3.18e-05	0.00335	CbGpPWpGaD
Pravastatin—SLCO1A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.1e-05	0.00326	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.09e-05	0.00325	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.02e-05	0.00318	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.97e-05	0.00313	CbGpPWpGaD
Pravastatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	2.92e-05	0.00307	CbGpPWpGaD
Pravastatin—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.91e-05	0.00307	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.87e-05	0.00303	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.8e-05	0.00294	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.71e-05	0.00285	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.66e-05	0.0028	CbGpPWpGaD
Pravastatin—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.65e-05	0.00279	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.64e-05	0.00278	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—IFNB1—peripheral nervous system neoplasm	2.61e-05	0.00275	CbGpPWpGaD
Pravastatin—SLCO2B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.57e-05	0.0027	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.54e-05	0.00268	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.5e-05	0.00263	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—GNS—peripheral nervous system neoplasm	2.5e-05	0.00263	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	2.48e-05	0.00261	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.45e-05	0.00258	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—KNG1—peripheral nervous system neoplasm	2.42e-05	0.00255	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—NME1—peripheral nervous system neoplasm	2.4e-05	0.00252	CbGpPWpGaD
Pravastatin—SLC16A1—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	2.39e-05	0.00252	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.35e-05	0.00248	CbGpPWpGaD
Pravastatin—SLC22A11—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.32e-05	0.00245	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—COX2—peripheral nervous system neoplasm	2.31e-05	0.00243	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.3e-05	0.00243	CbGpPWpGaD
Pravastatin—SLC16A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.28e-05	0.0024	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.21e-05	0.00233	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—GNS—peripheral nervous system neoplasm	2.19e-05	0.0023	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—GNAS—peripheral nervous system neoplasm	2.12e-05	0.00223	CbGpPWpGaD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.11e-05	0.00222	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—NME1—peripheral nervous system neoplasm	2.1e-05	0.00221	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.09e-05	0.0022	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.08e-05	0.00219	CbGpPWpGaD
Pravastatin—SLCO2B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.06e-05	0.00217	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	2.04e-05	0.00215	CbGpPWpGaD
Pravastatin—SLCO2B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.03e-05	0.00213	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—HGF—peripheral nervous system neoplasm	2.02e-05	0.00213	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—COX2—peripheral nervous system neoplasm	2.02e-05	0.00212	CbGpPWpGaD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2e-05	0.00211	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—GNS—peripheral nervous system neoplasm	1.92e-05	0.00202	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.87e-05	0.00197	CbGpPWpGaD
Pravastatin—SLC22A11—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.87e-05	0.00197	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—NME1—peripheral nervous system neoplasm	1.84e-05	0.00194	CbGpPWpGaD
Pravastatin—SLC22A11—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.83e-05	0.00193	CbGpPWpGaD
Pravastatin—SLC16A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.83e-05	0.00193	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—GNS—peripheral nervous system neoplasm	1.81e-05	0.0019	CbGpPWpGaD
Pravastatin—SLC16A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.8e-05	0.00189	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.79e-05	0.00188	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—COX2—peripheral nervous system neoplasm	1.77e-05	0.00187	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.77e-05	0.00187	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.75e-05	0.00185	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.73e-05	0.00183	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—NME1—peripheral nervous system neoplasm	1.73e-05	0.00183	CbGpPWpGaD
Pravastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.72e-05	0.00181	CbGpPWpGaD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.7e-05	0.00179	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—COX2—peripheral nervous system neoplasm	1.67e-05	0.00176	CbGpPWpGaD
Pravastatin—SLC22A7—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.66e-05	0.00175	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.65e-05	0.00174	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	1.63e-05	0.00172	CbGpPWpGaD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.61e-05	0.0017	CbGpPWpGaD
Pravastatin—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.59e-05	0.00168	CbGpPWpGaD
Pravastatin—SLCO1B3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.58e-05	0.00167	CbGpPWpGaD
Pravastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	1.58e-05	0.00166	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.57e-05	0.00166	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.52e-05	0.0016	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—ENO2—peripheral nervous system neoplasm	1.52e-05	0.0016	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.51e-05	0.00159	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	1.49e-05	0.00157	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.48e-05	0.00156	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.48e-05	0.00156	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.47e-05	0.00155	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.45e-05	0.00152	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.43e-05	0.00151	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.43e-05	0.0015	CbGpPWpGaD
Pravastatin—SLC22A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.4e-05	0.00147	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.39e-05	0.00147	CbGpPWpGaD
Pravastatin—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	1.38e-05	0.00145	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.36e-05	0.00143	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.35e-05	0.00142	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.32e-05	0.00139	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.32e-05	0.00139	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	1.29e-05	0.00136	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—BCHE—peripheral nervous system neoplasm	1.28e-05	0.00135	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.27e-05	0.00134	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.27e-05	0.00133	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.25e-05	0.00131	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.25e-05	0.00131	CbGpPWpGaD
Pravastatin—SLCO1A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.24e-05	0.00131	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	1.24e-05	0.0013	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.24e-05	0.0013	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.22e-05	0.00129	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—TH—peripheral nervous system neoplasm	1.2e-05	0.00127	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	1.2e-05	0.00126	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	1.19e-05	0.00125	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.19e-05	0.00125	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.18e-05	0.00125	CbGpPWpGaD
Pravastatin—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.17e-05	0.00123	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—ENO2—peripheral nervous system neoplasm	1.16e-05	0.00123	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.15e-05	0.00121	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	1.15e-05	0.00121	CbGpPWpGaD
Pravastatin—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.13e-05	0.00119	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.12e-05	0.00118	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	1.1e-05	0.00116	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—ENO2—peripheral nervous system neoplasm	1.1e-05	0.00115	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.08e-05	0.00114	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.07e-05	0.00112	CbGpPWpGaD
Pravastatin—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.06e-05	0.00112	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—TH—peripheral nervous system neoplasm	1.05e-05	0.00111	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.03e-05	0.00108	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1e-05	0.00106	CbGpPWpGaD
Pravastatin—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	9.84e-06	0.00104	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—BCHE—peripheral nervous system neoplasm	9.83e-06	0.00104	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—GNAS—peripheral nervous system neoplasm	9.83e-06	0.00103	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—ABCB1—peripheral nervous system neoplasm	9.64e-06	0.00102	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.38e-06	0.000988	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	9.26e-06	0.000975	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—TH—peripheral nervous system neoplasm	9.25e-06	0.000974	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	9.14e-06	0.000963	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.94e-06	0.000941	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—NRAS—peripheral nervous system neoplasm	8.85e-06	0.000932	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.83e-06	0.00093	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	8.7e-06	0.000916	CbGpPWpGaD
Pravastatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	8.62e-06	0.000908	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—GNAS—peripheral nervous system neoplasm	8.59e-06	0.000904	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	8.56e-06	0.000902	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	8.53e-06	0.000898	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—ABCB1—peripheral nervous system neoplasm	8.43e-06	0.000888	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.42e-06	0.000887	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.35e-06	0.000879	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	8.21e-06	0.000865	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.15e-06	0.000858	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	7.9e-06	0.000832	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	7.82e-06	0.000824	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	7.73e-06	0.000814	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—GNAS—peripheral nervous system neoplasm	7.55e-06	0.000795	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	7.5e-06	0.00079	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	7.42e-06	0.000781	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—ABCB1—peripheral nervous system neoplasm	7.41e-06	0.00078	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.37e-06	0.000776	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	7.26e-06	0.000765	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	7.24e-06	0.000763	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	7.11e-06	0.000749	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	7.1e-06	0.000748	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	6.97e-06	0.000734	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.94e-06	0.000731	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	6.84e-06	0.000721	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	6.81e-06	0.000717	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—TP53—peripheral nervous system neoplasm	6.77e-06	0.000713	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.74e-06	0.00071	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	6.61e-06	0.000696	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—HRAS—peripheral nervous system neoplasm	6.48e-06	0.000682	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	6.46e-06	0.00068	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.3e-06	0.000664	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	6.21e-06	0.000654	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	6.19e-06	0.000652	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	6.12e-06	0.000644	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	6.09e-06	0.000641	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	6.04e-06	0.000636	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	5.96e-06	0.000628	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	5.93e-06	0.000625	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	5.84e-06	0.000615	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.84e-06	0.000615	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	5.82e-06	0.000613	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	5.79e-06	0.000609	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	5.75e-06	0.000606	CbGpPWpGaD
Pravastatin—SLC16A1—Hemostasis—AKT1—peripheral nervous system neoplasm	5.72e-06	0.000602	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	5.62e-06	0.000592	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	5.57e-06	0.000587	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.51e-06	0.00058	CbGpPWpGaD
Pravastatin—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.42e-06	0.000571	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.31e-06	0.00056	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	5.19e-06	0.000546	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	5.07e-06	0.000534	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.98e-06	0.000524	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	4.7e-06	0.000495	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.61e-06	0.000485	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	4.49e-06	0.000473	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	4.38e-06	0.000462	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.36e-06	0.00046	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.18e-06	0.00044	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	4.12e-06	0.000434	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	3.98e-06	0.000419	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	3.91e-06	0.000412	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	3.82e-06	0.000402	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	3.8e-06	0.0004	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	3.69e-06	0.000388	CbGpPWpGaD
Pravastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.68e-06	0.000388	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	3.67e-06	0.000387	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	3.66e-06	0.000385	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.62e-06	0.000381	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	3.57e-06	0.000376	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	3.36e-06	0.000354	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	3.31e-06	0.000348	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	3.3e-06	0.000348	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.16e-06	0.000332	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	3.12e-06	0.000328	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	3.11e-06	0.000328	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	3.09e-06	0.000325	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.97e-06	0.000313	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.95e-06	0.00031	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	2.93e-06	0.000309	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	2.91e-06	0.000307	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	2.91e-06	0.000306	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	2.86e-06	0.000301	CbGpPWpGaD
Pravastatin—HMGCR—Metabolism—AKT1—peripheral nervous system neoplasm	2.65e-06	0.000279	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	2.54e-06	0.000267	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.41e-06	0.000254	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	2.39e-06	0.000252	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	2.37e-06	0.00025	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.35e-06	0.000247	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	2.33e-06	0.000245	CbGpPWpGaD
Pravastatin—SLC16A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.32e-06	0.000244	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.04e-06	0.000215	CbGpPWpGaD
Pravastatin—SLCO1B3—Metabolism—AKT1—peripheral nervous system neoplasm	2.04e-06	0.000215	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.94e-06	0.000205	CbGpPWpGaD
Pravastatin—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	1.92e-06	0.000202	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.92e-06	0.000202	CbGpPWpGaD
Pravastatin—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.6e-06	0.000169	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.56e-06	0.000165	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.53e-06	0.000162	CbGpPWpGaD
Pravastatin—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	1.37e-06	0.000144	CbGpPWpGaD
Pravastatin—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	1.27e-06	0.000133	CbGpPWpGaD
Pravastatin—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	9.08e-07	9.56e-05	CbGpPWpGaD
Pravastatin—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	7.87e-07	8.28e-05	CbGpPWpGaD
Pravastatin—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	6.85e-07	7.22e-05	CbGpPWpGaD
Pravastatin—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	6.46e-07	6.8e-05	CbGpPWpGaD
Pravastatin—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	6.4e-07	6.74e-05	CbGpPWpGaD
Pravastatin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	4.22e-07	4.45e-05	CbGpPWpGaD
